Clinical

Dataset Information

0

Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases


ABSTRACT: The purpose of this study is to evaluate efficacy and safety of mFOLFOX6+bevacizumab and mFOLFOX6+cetuximab for liver only metastasis from KRAS Exon 2 wild type (under protocol 1.0-1.2 edition) and RAS wild type (under protocol 2.0 edition) colorectal cancer.

DISEASE(S): Neoplasm Metastasis,Liver Only Metastasis From Kras Exon 2 Wild Type (under Protocol 1.0-1.2 Edition) And Ras Wild Type (under Protocol 2.0 Edition) Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2143514 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2012-06-25 | GSE36687 | GEO
2007-09-11 | E-MEXP-1240 | biostudies-arrayexpress
| PRJNA814287 | ENA
2006-08-09 | GSE5465 | GEO
2016-06-14 | GSE73090 | GEO
2007-12-26 | GSE6812 | GEO
| 2104278 | ecrin-mdr-crc
| PRJNA119105 | ENA
2023-10-01 | GSE185514 | GEO
2019-01-01 | GSE113154 | GEO